Wobenzym® News & Events
xxx
Summary Expert Panel
https://sportaerztezeitung.com/rubriken/therapie/5270/enzyme-therapy/
REMfresh® Patient Reported Outcomes Studies
1600 patients across three real world studies demonstrated significant improvements in sleep offset, duration, maintenance and quality.
SLEEP 2019
REMfresh® Duration Validation (REMVAL) and REMfresh® Short Sleep Cohort Assessment (REMSS)
SLEEP 2018
REMfresh® Patient-Reported Outcomes DURation (REMDUR)
SLEEP 2017
REM Absorption Kinetics Trial (REMAKT)
WORKS SAFELY...
No Pattern Of Side Effects... No Concern on Safety Profile
REMSU24 (REMfresh® Safety Update at 24 Months) - an adverse event reporting rate of only 0.016% with no serious adverse events reported in an estimated 320,255 patients.
WORKS WITH QUALITY...
Quality Ingredients, Pharmaceutical-Quality Manufacturing
Made with UltraMel®, a 99% ultrapure melatonin sourced from Western Europe, where melatonin is regulated as a drug.
Part of an FDA Drug Master File.
Manufactured in FDA-inspected facilities (cGMP standards).